|
Video: What is a Stock Split?
|
|
Instil Bio is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte (TIL) therapies for the treatment of patients with cancer. Co. is developing a class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR) platform. Co.'s product candidates designed to express CoStAR molecules to augment the activation of TILs in the tumor microenvironment, potentially leading to an increase in anti-tumor activity. Co.'s first CoStAR-TIL product candidate, ITIL-306, is an autologous TIL therapy genetically engineered to express a CoStAR molecule that recognizes FRa. According to our TIL split history records, Instil Bio has had 1 split. | |
|
Instil Bio (TIL) has 1 split in our TIL split history database. The split for TIL took place on December 08, 2023. This was a 1 for 20 reverse split, meaning for each 20 shares of TIL owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as Instil Bio conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the TIL split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Instil Bio shares, starting with a $10,000 purchase of TIL, presented on a split-history-adjusted basis factoring in the complete TIL split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/19/2021 |
|
End date: |
10/08/2024 |
|
Start price/share: |
$528.80 |
|
End price/share: |
$35.60 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-93.27% |
|
Average Annual Total Return: |
-53.15% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$673.11 |
|
Years: |
3.56 |
|
|
|
Date |
Ratio |
12/08/2023 | 1 for 20 |
|
|